Matthew Sinnreich - Oct 13, 2022 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
President and Acting CEO, Director
Signature
/s/ Dale S. Bergman as attorney-in-fact for Matthew Sinnreich
Stock symbol
OCEL
Transactions as of
Oct 13, 2022
Transactions value $
-$800
Form type
4
Date filed
10/17/2022, 06:00 AM
Previous filing
Jul 26, 2022
Next filing
Nov 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock, $0.001 par value Sale -$800 -20K -0.29% $0.04 6.98M Oct 13, 2022 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock held by Retrograde Investments, LLC, in which entity the Reporting Person is a minority holder and over which the Reporting Person has shared voting and dispositive power.

Remarks:

Exhibit List - Exhibit 24 Power of attorney